NCT01214122View on ClinicalTrials.gov

A Drug-Drug Interaction Study Between AZD9668 and Warfarin to Study the Effect of AZD9668 on the Metabolism and Effect of Warfarin

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
PharmacokineticsPharmacodynamics
Interventions
DRUG

AZD9668

60 mg orally twice daily for 11 days

DRUG

Warfarin

10 x 2.5 (25) mg orally once daily on day 1 and on day 14

Trial Locations (2)

Unknown

Research Site, Linköping

Research Site, Uppsala

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY